Day One Announces Updated FIREFLY-1 Data for Tovorafenib
Today, Day One Announces Updated FIREFLY-1 Data for Tovorafenib and Completion of Rolling New Drug Application (NDA) submission to U.S....
Day One Announces Updated FIREFLY-1 Data for Tovorafenib
LBF teams up with LBF Hero Maddie to Continue to Drive Change for DE&I in Pediatric Cancer Treatment
Children’s National Hospital Receives $96 Million for Rare Brain Tumor Research & Care
FIRST-OF-ITS-KIND OPEN-ANALYSIS PLATFORM FOR PEDIATRIC BRAIN TUMORS PROVIDES ROBUST DATA RESOURCE
Cancer Treatments for Kids
MEDIA ALERT Pediatric Brain Cancer Nonprofit, Lilabean Foundation, Hosts Junior Karting Invitational
The LBF 2022 Impact Report
Better Treatment Option for some Low-Grade Glioma Patients Becomes a Reality
ABC7 News Sits Down with LBF to Shed Light on Importance of Pediatric Brain Cancer Research
LBF is Supporting our Community Again this Holiday Season through the LBF Brain Cancer Family Relief
The 2022 LBF Fall Ball Raises over Half a Million Dollars to Further Research
A Mid-Year Reflection from our Founder
Following Her Lead: A Mother’s Journey through Pediatric Brain Cancer
LBF Supports New Position at the Brain Tumor Institute at Children’s National Hospital
First-ever LBF Giving Circle Helps to Fund CBTN Pre-Clinical Model Program with $20,000 Gift
The 5th Annual LBF Birdies for Brain Cancer Raises Over $190,000
Q&A With LBF Hero, Zoe FitzGerald
LBF Creates Ukrainian Pediatric Cancer Relief Fund to Help Provide Basic Needs
Proteogenomics In Low-Grade Gliomas Project Update
Lilabean Foundation Commits $650,000 to Children’s Brain Tumor Network to Advance Precision Research
Looking to help fund a cure? Donate today!